○Noe Kawade¹, Okiru Komine¹, Akira Sobue¹, Takashi Saito², Takaomi C Saido³, Koji Yamanaka¹ (1. Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University., 2. Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences., 3. Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science.)

○Okiru Komine¹, Akira Sobue¹, Takashi Saito², Koji Yamanaka¹ (1. Research Institute of Environmental Medicine, Nagoya University, 2. Institute of Brain Science, Nagoya City University Graduate school of Medical Science)

○Akiko Amano¹, Nobuo Sanjo¹, Wataru Araki¹, Yasutaka Anraku^2,8, Makoto Nakakido^2,3, Etsuro Matsubara⁴, Tetsuya Nagata^1,5, Kouhei Tsumoto^2,3,6, Takami Tomiyama⁷, Kazunori Kataoka⁸, Takanori Yokota^1,5 (1. Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 2. Department of Bioengineering, School of Engineering, The University of Tokyo, 3. Department of Chemistry & Biotechnology, School of Engineering, The University of Tokyo, 4. Department of Neurology, Oita University, 5. NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, 6. The Institute of Medical Science, The University of Tokyo, 7. Department of Translational Neuroscience, Osaka Metropolitan University Graduate School of Medicine, 8. Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion)

○Ding-I Yang¹, Wan-Tze Chen¹, Hui-Yu Hsu² (1. Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan, 2. Mynature Biotech Inc., Yilan, Taiwan)

○Yung-Feng Liao¹, Po-Fan Wu¹, Yun-Wen Chen¹ (1. Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan)